Karuna Therapeutics (KRTX) Price-to-Earnings (P/E) Ratio
Price: $329.83
Market Cap: $12.60B
Avg Volume: 971.83K
Market Cap: $12.60B
Avg Volume: 971.83K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Karuna Therapeutics's P/E ratios across different time periods:
- TTM: -37.08
- Annual: -26.97
- Quarterly: -26.26
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 9.33
- Price-to-Sales (P/S) Ratio: 17886.71
Annual Ratios
Karuna Therapeutics Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-37.08
P/B Ratio (Annual)
9.33
P/S Ratio (Annual)
17886.71
Karuna Therapeutics Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2023 | -26.97 | 9.33 | 17886.71 |
| 2022 | -22.49 | 5.52 | 584.29 |
| 2021 | -26.54 | 7.60 | 103.27 |
| 2020 | -39.19 | 7.93 | 0.00 |
| 2019 | -20.09 | 2.31 | 0.00 |
| 2018 | -12.42 | 2.38 | 0.00 |
| 2017 | -24.63 | -11.11 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for KRTX.